Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Special Focus: Pediatric Neuro-Oncology"'
Autor:
Tomonori Higuchi, Keiji Shimada, Mitsutoshi Nakamura, Noboru Konishi, Hiroyuki Nakase, Toshisuke Sakaki, Eiwa Ishida
Publikováno v:
Neuro-Oncology. 9:113-123
Astrocytomas are the most common pediatric brain tumors, accounting for 7%-8% of all childhood cancers. Relatively few studies have been performed on their molecular properties; therefore, classification of pediatric astrocytic tumors into genetic su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e7e1668e7e97edef079bd69400af291
https://doi.org/10.1215/15228517-2006-036
https://doi.org/10.1215/15228517-2006-036
Publikováno v:
Neuro-Oncology. 9:124-134
Gangliogliomas are generally benign tumors, composed of transformed neuronal and glial elements, with rare malignant progression of the glial component. The current study of a rare case of a woman harboring a ganglioglioma with areas of malignant tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::075102b6b3e44fa631ed05e5766c0af9
https://doi.org/10.1215/15228517-2006-029
https://doi.org/10.1215/15228517-2006-029
Autor:
Allan H. Friedman, Sridharan Gururangan, James E. Herndon, Jeanne Krauser, Michael Fisher, David A. Reardon, Jeffrey C. Allen, Henry S. Friedman, James J. Vredenburgh, Annick Desjardins, Melody A. Watral, Jennifer A. Quinn, Peter C. Phillips
Publikováno v:
Neuro-Oncology. 9:161-168
We conducted a phase II study to assess the efficacy of oral temozolomide (TMZ) in children with progressive low-grade glioma. Thirty eligible patients were enrolled on this study. Median age at enrollment was 10 years (range, 4-18 years). Eligible p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1bf28b26f216eaafc37dd46c92abb6b
https://doi.org/10.1215/15228517-2006-030
https://doi.org/10.1215/15228517-2006-030
Autor:
Beverly L. Davidson, Rajeev Vibhakar, Gi-Yung Ryu, Jae-Geun Yoon, Lorie Field, Hwahyung Lee, Greg Foltz, Anup Madan, Jessica Pierson
Medulloblastoma is a heterogeneous pediatric brain tumor with significant therapy-related morbidity, its five-year survival rates ranging from 30% to 70%. Improvement in diagnosis and therapy requires better understanding of medulloblastoma pathology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfceb603bd36f114f1b373d304a6c051
https://europepmc.org/articles/PMC1871668/
https://europepmc.org/articles/PMC1871668/
Autor:
Ian F, Pollack, Regina I, Jakacki, Susan M, Blaney, Michael L, Hancock, Mark W, Kieran, Peter, Phillips, Larry E, Kun, Henry, Friedman, Roger, Packer, Anu, Banerjee, J Russell, Geyer, Stewart, Goldman, Tina Young, Poussaint, Matthew J, Krasin, Yanfeng, Wang, Michael, Hayes, Anthony, Murgo, Susan, Weiner, James M, Boyett
Publikováno v:
Neuro-oncology. 9(2)
This study estimated the maximum tolerated dose (MTD) of imatinib with irradiation in children with newly diagnosed brainstem gliomas, and those with recurrent malignant intracranial gliomas, stratified according to use of enzyme-inducing anticonvuls
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1b87dec37db3f3323fe06c8c79cebee
https://pubmed.ncbi.nlm.nih.gov/17293590
https://pubmed.ncbi.nlm.nih.gov/17293590